Drug Trial Radar · NCT00844662
Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer Hydrochloride
Last checked: Nov 20, 2026Latest source record: Oct 19, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
1,000
Planned (sponsor's estimate)
Start
Jul 2009
Primary completion
Sep 2011
Study completion Oct 2011
Sponsor
- Lead sponsor
- Ineos Healthcare LimitedIndustry
- Sponsor type
- Industry
- First posted
- Feb 16, 2009
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Magnesium iron hydroxycarbonate is a phosphate binder that absorbs phosphate from food, reducing the amount that the body can absorb. The purpose of this study is to assess the efficacy of magnesium iron hydroxycarbonate in subjects requiring haemodialysis, compared with a marketed phosphate binder, sevelamer hydrochloride.
Conditions
- Chronic Kidney Failure
Interventions
FermagateDrug
Film coated tablet 500mg
Sevelamer hydrochlorideDrug
Tablet 800mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Control or not the level of serum phosphateTime frame: Within the treatment period
Locations
109 sites in 15 countries. Site status is shown where the registry gives one.
Arkansas Nephrology Services Ltd
Hot Springs, Arkansas
National Institute of Clinical Research
Bakersfield, California
Renal Medical Associates
Lynwood, California
Academic Medical Research Institute Inc
Monterey Park, California
Pasadena Nephrology
Pasadena, California
Sierra View Nephrology SC
Porterville, California
Kidney Center Inc.
Thousand Oaks, California
Stanford Nephrology
Stamford, Connecticut
Capitol Dialysis
Washington D.C., District of Columbia
Discovery Medical Research Group Inc.
Ocala, Florida
Cleveland William MD
Atlanta, Georgia
Davita South Brunswick Dialysis Center
Brunswick, Georgia
North Shore University Health System
Evanston, Illinois
Southwest Nephrology Associates
Evergreen Park, Illinois
Loyola University Medical Center
Maywood, Illinois
Renal Associates of Baton Rouge
Baton Rouge, Louisiana
Western New England Transplant Associates
Springfield, Massachusetts
Hurley Medical Center
Flint, Michigan
Washington University School of Medicine
St Louis, Missouri
Huq Cruz Strauss Masud PA
Neptune City, New Jersey
St. Joseph's Regional Medical Center
Paterson, New Jersey
Nassau Nephrology, LLP
Bellmore, New York
Clinical Research Development Associates LLC
Springfield Gardens, New York
Nephrology Associates, PA
Winston-Salem, North Carolina
Bayview Nephrology
Erie, Pennsylvania
Renal Endocrine Associates PC
Pittsburgh, Pennsylvania
Renal-Endocrine Associates
Pittsburgh, Pennsylvania
CSRA Renal Services
Aiken, South Carolina
Carolina Diabetes & Kidney Center
Sumter, South Carolina
Carolina Diabetes and Kidney Center/ sumter Medical Specialist
Sumter, South Carolina
South Arlington Dialysis Center
Arlington, Texas
U.S Renal Care
Grand Prairie, Texas
U.S. Renal Care
Grand Prairie, Texas
Diagnostic Clinic of Houston
Houston, Texas
SouthWest Houston Research LTD.
Houston, Texas
Renal Associates PA
San Antonio, Texas
University of Vermont
Burlington, Vermont
Ramon Mendez MD PC (private practice)
Alexandria, Virginia
Ramon Mendez, MD, PC (private practice)
Alexandria, Virginia
Clinical Research & Consulting Center LLC
Fairfax, Virginia
Showing 40 of 109 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.